We also found that CCR2+/CX3CR1+ M-MDSCs express iNOS in the glioma microenvironment and inhibition of NOS with L-NMMA could recover in vitro proliferation of CD8 T cells, but not CD4 T cell proliferation. The gene discussed is CCR2; the disease is central nervous system cancer.